NO20015966L - Tricykliske analgetika - Google Patents

Tricykliske analgetika

Info

Publication number
NO20015966L
NO20015966L NO20015966A NO20015966A NO20015966L NO 20015966 L NO20015966 L NO 20015966L NO 20015966 A NO20015966 A NO 20015966A NO 20015966 A NO20015966 A NO 20015966A NO 20015966 L NO20015966 L NO 20015966L
Authority
NO
Norway
Prior art keywords
alkyl
hydrogen
alkenyl
cycloalkyl
tricyclic
Prior art date
Application number
NO20015966A
Other languages
English (en)
Norwegian (no)
Other versions
NO20015966D0 (no
Inventor
Alain Calvet
Henri Jacobelli
Jocelyne Puaud
Francois Joseph Roman
Jacques Hamon
Agnes Grouhel
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20015966D0 publication Critical patent/NO20015966D0/no
Publication of NO20015966L publication Critical patent/NO20015966L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20015966A 1999-06-07 2001-12-06 Tricykliske analgetika NO20015966L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13786899P 1999-06-07 1999-06-07
PCT/EP2000/005783 WO2000075116A2 (en) 1999-06-07 2000-06-07 Tricyclic analgesics

Publications (2)

Publication Number Publication Date
NO20015966D0 NO20015966D0 (no) 2001-12-06
NO20015966L true NO20015966L (no) 2001-12-06

Family

ID=22479397

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015966A NO20015966L (no) 1999-06-07 2001-12-06 Tricykliske analgetika

Country Status (21)

Country Link
EP (1) EP1235808A2 (sk)
JP (1) JP2003513006A (sk)
KR (1) KR20020010923A (sk)
CN (1) CN1635998A (sk)
AP (1) AP2001002356A0 (sk)
AU (1) AU6428400A (sk)
BG (1) BG106162A (sk)
BR (1) BR0011427A (sk)
CA (1) CA2376076A1 (sk)
EA (1) EA200101117A1 (sk)
HR (1) HRP20010913A2 (sk)
HU (1) HUP0203317A2 (sk)
IL (1) IL146755A0 (sk)
IS (1) IS6175A (sk)
MA (1) MA26795A1 (sk)
MX (1) MXPA01012694A (sk)
NO (1) NO20015966L (sk)
PL (1) PL357340A1 (sk)
SK (1) SK17512001A3 (sk)
TR (1) TR200103531T2 (sk)
WO (1) WO2000075116A2 (sk)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
FR2915099B1 (fr) * 2007-04-19 2009-06-05 Sanofi Aventis Sa Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens
ES2573497T3 (es) * 2011-02-02 2016-06-08 Vertex Pharmaceuticals Incorporated Pirrolopirazin-amidas de piperidina espirocíclicas como moduladores de canales iónicos
CN115872873A (zh) * 2022-12-29 2023-03-31 上海泰坦科技股份有限公司 一种双（2-溴乙基）胺氢溴酸盐的重结晶纯化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8917069D0 (en) * 1989-07-26 1989-09-13 Merck Sharp & Dohme Therapeutic agents
IL96507A0 (en) * 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
AU693087B2 (en) * 1993-01-28 1998-06-25 Merck & Co., Inc. Spiro-substituted azacycles as tachykinin receptor antagonists
US5439914A (en) * 1994-02-18 1995-08-08 Merck & Co., Inc. Spirocycles
AU5604998A (en) * 1996-12-13 1998-07-03 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity
US6013644A (en) * 1997-12-12 2000-01-11 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity

Also Published As

Publication number Publication date
WO2000075116A3 (en) 2002-07-04
NO20015966D0 (no) 2001-12-06
TR200103531T2 (tr) 2002-06-21
IL146755A0 (en) 2002-07-25
EP1235808A2 (en) 2002-09-04
SK17512001A3 (sk) 2002-11-06
AP2001002356A0 (en) 2001-12-31
EA200101117A1 (ru) 2002-06-27
AU6428400A (en) 2000-12-28
IS6175A (is) 2001-11-23
CA2376076A1 (en) 2000-12-14
HUP0203317A2 (hu) 2003-02-28
JP2003513006A (ja) 2003-04-08
HRP20010913A2 (en) 2003-04-30
CN1635998A (zh) 2005-07-06
MXPA01012694A (es) 2003-10-15
KR20020010923A (ko) 2002-02-06
MA26795A1 (fr) 2004-12-20
PL357340A1 (en) 2004-07-26
BG106162A (bg) 2002-05-31
BR0011427A (pt) 2002-03-26
WO2000075116A2 (en) 2000-12-14

Similar Documents

Publication Publication Date Title
HUP0000079A2 (hu) Indán- és dihidroindolszármazékok
HRP20020175B1 (en) N-heterocyclikc derivatives as nos inhibitors
MY129796A (en) Novel anti-inflammatory androstane derivatives
TR200003332T2 (tr) İzoksazolin-3-il-asil benzen üretmek için yöntem
NO982913L (no) Kinolin- og kinazolinforbindelser nyttige i terapi
HUP0300268A2 (hu) Herbicid hatású benzoilpirazolszármazékok, ilyeneket tartalmazó készítmények és alkalmazásuk
NO985820L (no) Cytokinproduksjonsinhibitor, triazepinforbindelse og mellomprodukter for disse
IS4588A (is) Bensimídazól efnasambönd, lyfjablöndur sem innihalda efnasamböndin og notkun þeirra
NO20053960L (no) Piperidin-benzensulfonamidderivater
SE9801474D0 (sv) Quinoline Derivatives
HUP9903836A2 (hu) Új eljárás Cox-2 inhibítor hatású fenil-szubsztituált 2(5H)-furanonok előállítására
CO4700452A1 (es) Derivados de indol
ATE182889T1 (de) Bicyclische amidinderivate als no-synthetase inhibitoren
BG105299A (en) Substituted amidazo[1,2a]azines as selective inhibitors of cox-2
DE59808284D1 (de) Cycloalkylalkancarbonsäureamide, deren herstellung und verwendung
NO20015966L (no) Tricykliske analgetika
ATE121385T1 (de) Harnstoffderivate, ihre herstellung und ihre verwendung bei der therapie.
ES2191341T3 (es) Derivados de la 2-fenoxianilina.
FI942928A (fi) Fenyleenidialkanoaattien aromaattiset esterit ihmisen neutrofiili-elastaasin inhibiittoreina
NO932024D0 (no) Indanderivater
CO5160345A1 (es) Nuevos androgenos oralmente activos derivados de 7 alfa- metil-19-nortestosterona
NO995289L (no) Benzimidazol-derivater
EA200401099A1 (ru) Производные гетероциклического амида
NZ333229A (sk)
IT1255207B (it) Composizioni farmaceutuche ad attivita' antiaggregante e vasodilatatrice

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application